Fate therapeutics announces eight presentations at the 2021 ash annual meeting

Ft596 oral and ft516 poster presentations to highlight updated clinical data for relapsed / refractory lymphoma on monday, december 13

FATE Ratings Summary

FATE Quant Ranking